Cerebrum
Natural health product licensed in Canada
- Licence holder
- ReNew Life Canada Ltd.
- NPN or DIN-HM
- 80061669
- Status
- Active licence
- Licence date
- 8 June 2015
- Revision date
- 24 September 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 33.3 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 33.3 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 5 mg | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 5 mg | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 27 mg Eicosapentaenoic acid | 900 mg | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 27 mg Eicosapentaenoic acid | 900 mg | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 540 mg Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 540 mg Docosahexaenoic acid | Not specified | Not calculated |
| Panax quinquefolius Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 800 mg Potency : 10.65 % Ginsenosides | 200 mg | Not calculated |
Non-medicinal ingredients
Poudre de caroube, Mélange de concentré de tocophérols, Lécithine, Astaxanthine, Eau purifiée, Saveur d'orange, Dioxyde de silicium, Maltodextrine, Glycérine, Cire d'abeille, Huile de tournesol, Palmitate d'ascorbyle, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps support cognitive health and/or brain function. Digestive Enzyme. Helps temporarily support working memory and attention accuracy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80061669
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging